Fecal calprotectin for the diagnosis of bowel inflammation in patients with rheumatological diseases: a systematic review.

Date publication

décembre 2019

Journal

Journal of Crohn's & colitis

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Fauny M, D'Amico F, Bonovas S, Netter P, Danese S, Loeuille D, Peyrin-Biroulet L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/31858121

Résumé

Endoscopic and histologic gut inflammation are present in half of patients with ankylosing spondylitis (AS) or spondyloarthritis (SpA). We performed a systematic literature review on the use of fecal calprotectin (FC) in patients with rheumatic diseases.

Mots clés

Fecal calprotectin, ankylosing spondylitis, inflammatory bowel disease, spondyloarthritis

Référence

J Crohns Colitis. 2019 Dec 20;: